Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

An Insider Bought Dow Component UnitedHealth

Page 1 of 2

A Form 4 filed with the SEC has disclosed that Rodger Lawson, a member of the Board of Directors at UnitedHealth Group Inc. (NYSE:UNH), bought 2,000 shares on January 18th at an average price of $54.42 per share. Lawson now owns close to 17,000 shares of the stock directly. UnitedHealth, a health insurer who joined the Dow Jones Industrial Average last year, has risen 25% since a year ago. Insiders should hesitate to purchase more shares of the company’s stock, since they already benefit financially when business is good and see their income decline in bad times. The exception would be if the benefits of diversifying are trumped by a particularly strong chance of a gain in the stock price; this in our view is why stocks bought by insiders tend to do well (read more about studies on insider trading).


UnitedHealth’s revenue was up 11% in the fourth quarter of 2012 compared to the same period in 2011, but margins contracted and as a result earnings were actually down slightly. The 12% growth rate in medical costs was particularly notable. For the year as a whole, the company reported a 9% increase in sales and a 7% increase in net income. The market capitalization of $58 billion- the largest among publicly traded health insurers- values UnitedHealth at 11 times trailing earnings. Analyst expectations are for low growth in the next couple years and so current-year and 2013 P/Es are in the 9-10 range. These are low valuations, and even if the company does not see much of an increase in earnings it could be a good buy at these prices. We’d also note that UnitedHealth Group Inc. has a beta of 0.5, indicating that it is somewhat protected from market downturns.

UnitedHealth Group Inc. was one of the most popular healthcare stocks among hedge funds in the third quarter of 2012, according to our database of 13F filings (find more healthcare stocks hedge funds loved). Billionaire Dan Loeb’s Third Point reported a position of 2 million shares, an 11% increase from three months earlier (see more of Loeb’s stock picks). Renaissance Technologies, whose founder Jim Simons is now a billionaire, and fellow billionaire Leon Cooperman’s Omega Advisors were two other hedge funds with significant positions in UnitedHealth. Check out more favorite stocks from Renaissance Technologies and from Omega Advisors.

Recent performance and valuation at UnitedHealth turns out to be similar to that of its peers:

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!